Suppr超能文献

高迁移率族蛋白 B1(HMGB1)诱导 Toll 样受体 4(TLR4)二聚体形成的机制研究。

Mechanistic insights into high mobility group box-1 (HMGb1)-induced Toll-like receptor 4 (TLR4) dimer formation.

机构信息

a Center for Molecular Innovation , The Feinstein Institute for Medical Research , Manhasset , NY 11030 , USA.

出版信息

J Biomol Struct Dyn. 2019 Sep;37(14):3721-3730. doi: 10.1080/07391102.2018.1526712. Epub 2018 Dec 10.

Abstract

Supplemental data for this article can be accessed here.High mobility group box-1 (HMGb1), an endogenous danger-associated molecular pattern protein (DAMP) whose extracellular release has been associated with sterile injury and various inflammatory diseases and conditions, has been shown to be a valuable clinical drug target. Elucidation of the specific interactions with the HMGb1 receptor, Toll-like receptor 4 (TLR4) and adaptor protein myeloid differentiation factor-2 (MD-2), will lead to more precisely targeted therapeutics. We sought to examine detailed interactions and dynamics of the HMGb1 A-box and B-box fragments, as well as the intact protein using protein-protein docking (ZDOCK, ZRANK) and molecular dynamics (Schrödinger Desmond, New York, NY). Mutagenesis and SPR-binding studies allowed us to draw further conclusions regarding the details of the HMGb1-TLR4-MD2 interaction and shed light on the reasons for the opposing biological activities of HMGb1 A-box and B-box fragments. From our findings, we hypothesize that disulfide A-box fragment binds as an anchor toward the TLR4-MD-2 but does not facilitate the TLR4 dimer formation, thereby competing with the HMGb1-binding site and preventing HMGb1-induced signaling and downstream inflammation, whereas the pro-inflammatory B-box fragment retains the MD-2 active conformation and binds to both TLR4 proteins in the complex to aid TLR4 dimer formation, which activates the intracellular signaling for downstream inflammatory pathways and cytokine release. Communicated by Ramaswamy H. Sarma.

摘要

本文补充资料可在此处获取。高迁移率族蛋白 B1(HMGb1)是一种内源性危险相关分子模式蛋白(DAMP),其细胞外释放与非感染性损伤和各种炎症性疾病和病症有关,已被证明是一种有价值的临床药物靶点。阐明与 HMGb1 受体、Toll 样受体 4(TLR4)和衔接蛋白髓样分化因子-2(MD-2)的特定相互作用,将导致更精确靶向的治疗方法。我们试图使用蛋白质-蛋白质对接(ZDOCK、ZRANK)和分子动力学(Schrödinger Desmond,纽约,NY)来检查 HMGb1 A 盒和 B 盒片段以及完整蛋白质的详细相互作用和动力学。突变和 SPR 结合研究使我们能够进一步了解 HMGb1-TLR4-MD2 相互作用的细节,并阐明 HMGb1 A 盒和 B 盒片段具有相反生物学活性的原因。根据我们的发现,我们假设二硫键 A 盒片段作为锚定物结合到 TLR4-MD-2 上,但不促进 TLR4 二聚体形成,从而与 HMGb1 结合位点竞争,并阻止 HMGb1 诱导的信号转导和下游炎症,而促炎 B 盒片段保留 MD-2 活性构象,并结合到复合物中的两个 TLR4 蛋白上,以辅助 TLR4 二聚体形成,这激活了下游炎症途径和细胞因子释放的细胞内信号转导。由 Ramaswamy H. Sarma 传达。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验